Conquering Diseases

Study Of An Investigational Vaccine Against Epstein Barr Virus


Seeking healthy men and women volunteers aged 18-55 for a study of an investigational vaccine against Epstein Barr Virus which is the main cause of mononucleosis.


Participants in this study will receive either one of four doses of the investigational vaccine or a placebo (looks like the vaccine but contains no medicine). The vaccine or placebo will be administered as three shots over a period of 6 months. There will be up to 10 office visits and 6 phone visits for the study over 13 months.

What we're hoping for

We are studying whether an investigational vaccine is safe and effective in preventing infection with Epstein Barr Virus (EBV)

Additional Information Identifier: NCT05831111

 Principal Investigator

Katherine  Luzuriaga, MD

UMass Chan Medical School

 Study Contact

The Clinical Research  Center



UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655